ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACIU AC Immune SA

3.25
-0.16 (-4.69%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 550,828
Bid Price 3.09
Ask Price 3.30
News -
Day High 3.40

Low
1.90

52 Week Range

High
5.14

Day Low 3.095
Share Name Share Symbol Market Stock Type
AC Immune SA ACIU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.16 -4.69% 3.25 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.375 3.095 3.40 3.18 3.41
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,193 550,828 US$ 3.31 US$ 1,824,312 - 1.90 - 5.14
Last Trade Type Quantity Price Currency
18:19:18 8 US$ 3.25 USD

AC Immune (ACIU) Options Flow Summary

Overall Flow

Bearish

Net Premium

-33k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

AC Immune SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
315.45M 99.20M - 3.94M -70.75M -0.71 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AC Immune News

Date Time Source News Article
5/16/202413:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/13/202405:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/13/202405:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/09/202415:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202406:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202415:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202407:10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy..
12/28/202315:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/19/202307:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/15/202316:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
12/15/202315:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/15/202306:27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACIU Message Board. Create One! See More Posts on ACIU Message Board See More Message Board Posts

Historical ACIU Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.353.722.293.337,469,4890.9038.30%
1 Month2.403.722.253.272,002,1570.8535.42%
3 Months3.234.07992.253.23809,6460.020.62%
6 Months2.995.142.253.32457,1990.268.70%
1 Year2.165.141.903.31489,5651.0950.46%
3 Years6.4512.611.685.52453,612-3.20-49.61%
5 Years5.1014.891.686.19422,157-1.85-36.27%

AC Immune Description

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

Your Recent History

Delayed Upgrade Clock